Literature DB >> 14501972

Role of brain death and the dead-donor rule in the ethics of organ transplantation.

Robert D Truog1, Walter M Robinson.   

Abstract

The "dead-donor rule" requires patients to be declared dead before the removal of life-sustaining organs for transplantation. The concept of brain death was developed, in part, to allow patients with devastating neurologic injury to be declared dead before the occurrence of cardiopulmonary arrest. Brain death is essential to current practices of organ retrieval because it legitimates organ removal from bodies that continue to have circulation and respiration, thereby avoiding ischemic injury to the organs. The concept of brain death has long been recognized, however, to be plagued with serious inconsistencies and contradictions. Indeed, the concept fails to correspond to any coherent biological or philosophical understanding of death. We review the evidence and arguments that expose these problems and present an alternative ethical framework to guide the procurement of transplantable organs. This alternative is based not on brain death and the dead-donor rule, but on the ethical principles of nonmaleficence (the duty not to harm, or primum non nocere) and respect for persons. We propose that individuals who desire to donate their organs and who are either neurologically devastated or imminently dying should be allowed to donate their organs, without first being declared dead. Advantages of this approach are that (unlike the dead-donor rule) it focuses on the most salient ethical issues at stake, and (unlike the concept of brain death) it avoids conceptual confusion and inconsistencies. Finally, we point out parallel developments, both domestically and abroad, that reflect both implicit and explicit support for our proposal.

Entities:  

Keywords:  Analytical Approach; Death and Euthanasia; Health Care and Public Health; Uniform Determination of Death Act

Mesh:

Year:  2003        PMID: 14501972     DOI: 10.1097/01.CCM.0000090869.19410.3C

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

Review 1.  Unraveling the pathogenesis of Parkinson's disease--the contribution of monogenic forms.

Authors:  V Bonifati; B A Oostra; P Heutink
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

Review 2.  Law and medical ethics in organ transplantation surgery.

Authors:  Tom Woodcock; Robert Wheeler
Journal:  Ann R Coll Surg Engl       Date:  2010-05       Impact factor: 1.891

3.  Defining death: when physicians and families differ.

Authors:  J M Appel
Journal:  J Med Ethics       Date:  2005-11       Impact factor: 2.903

4.  Consent for organ retrieval cannot be presumed.

Authors:  Mike Collins
Journal:  HEC Forum       Date:  2009-03

5.  The self-fulfilling prophecy in intensive care.

Authors:  Dominic Wilkinson
Journal:  Theor Med Bioeth       Date:  2009

6.  Renaissance of criticism on the concept of brain death--the role of legal medicine in the context of the interdisciplinary discussion.

Authors:  L Markert; B Bockholdt; M A Verhoff; S Heinze; M Parzeller
Journal:  Int J Legal Med       Date:  2015-07-15       Impact factor: 2.686

Review 7.  Does it matter that organ donors are not dead? Ethical and policy implications.

Authors:  M Potts; D W Evans
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

8.  The diagnosis of death and the irreducibility of the human person.

Authors:  Richard H Bulzacchelli
Journal:  Linacre Q       Date:  2013-02

9.  In defense of the reverence of all life: Heideggerean dissolution of the ethical challenges of organ donation after circulatory determination of death.

Authors:  D J Isch
Journal:  Med Health Care Philos       Date:  2007-05-02

10.  Are terminally ill patients dying in the ICU suitable for non-heart beating organ donation?

Authors:  Jean-Pierre Revelly; Luca Imperatori; Philippe Maravic; Marie-Denise Schaller; René Chioléro
Journal:  Intensive Care Med       Date:  2006-03-14       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.